Allianz Asset Management Gmb H Pro Qr Therapeutics N.V. Transaction History

Allianz Asset Management Gmb H

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.5 - $6.53 $109,800 - $159,332	-24,400 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$5.25 - $9.9 $376,267 - $709,533	-71,670 Reduced 74.6%	24,400 $134,000
Q4 2019 Feb 13, 2020	BUY	$5.84 - $10.51 $379,278 - $682,571	64,945 Added 208.66%	96,070 $953,000
Q3 2019 Nov 13, 2019	SELL	$5.76 - $9.44 $43,200 - $70,800	-7,500 Reduced 19.42%	31,125 $181,000
Q2 2019 Aug 08, 2019	SELL	$9.1 - $15.55 $32,032 - $54,736	-3,520 Reduced 8.35%	38,625 $352,000
Q1 2019 May 13, 2019	BUY	$12.5 - $18.48 $39,187 - $57,934	3,135 Added 8.04%	42,145 $584,000
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $594,902 - $873,824	39,010 New	39,010 $613,000

17.4M

37.7K

21.3K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $258M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.